Relay Therapeutics, Inc. (RLAY)
16.28
-1.02
(-5.90%)
USD |
NASDAQ |
Oct 16, 16:00
16.20
-0.08
(-0.49%)
After-Hours: 20:00
Relay Therapeutics Net Income (TTM) : -286.04M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -286.04M |
| March 31, 2026 | -272.70M |
| December 31, 2025 | -276.48M |
| September 30, 2025 | -297.59M |
| June 30, 2025 | -311.55M |
| March 31, 2025 | -333.39M |
| December 31, 2024 | -337.71M |
| September 30, 2024 | -345.20M |
| June 30, 2024 | -322.83M |
| March 31, 2024 | -329.12M |
| December 31, 2023 | -341.97M |
| September 30, 2023 | -325.98M |
| June 30, 2023 | -344.42M |
| March 31, 2023 | -322.70M |
| Date | Value |
|---|---|
| December 31, 2022 | -290.51M |
| September 30, 2022 | -290.46M |
| June 30, 2022 | -267.12M |
| March 31, 2022 | -383.73M |
| December 31, 2021 | -363.87M |
| September 30, 2021 | -261.14M |
| June 30, 2021 | -236.38M |
| March 31, 2021 | -69.71M |
| December 31, 2020 | -52.41M |
| September 30, 2020 | -111.60M |
| June 30, 2020 | -95.20M |
| March 31, 2020 | -86.01M |
| December 31, 2019 | -75.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -32.46M |
| TG Therapeutics, Inc. | 441.49M |
| Karyopharm Therapeutics, Inc. | -224.74M |
| Spyre Therapeutics, Inc. | -168.22M |
| Akebia Therapeutics, Inc. | -29.67M |